Assessment of Heparin Binding Protein for the Prediction of Severe Sepsis
Status: | Active, not recruiting |
---|---|
Conditions: | Hospital, Hospital |
Therapuetic Areas: | Other |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 1/11/2019 |
Start Date: | March 27, 2017 |
End Date: | March 1, 2019 |
Prospective, Non-interventional, Multi-centre Clinical Study to Assess the Clinical Validity of the HBP Assay to Predict Development of Severe Sepsis in Patients With Suspected Infection Following ED Admission
The purpose of this prospective, non-interventional, multi-centre clinical study is to assess
the clinical validity of the Heparin Binding Protein (HBP) assay for indicating the presence,
or outcome, of severe sepsis (including septic shock), over 72 hours, in patients with
suspected infection following emergency department admission.
the clinical validity of the Heparin Binding Protein (HBP) assay for indicating the presence,
or outcome, of severe sepsis (including septic shock), over 72 hours, in patients with
suspected infection following emergency department admission.
The primary objective of this study is to use HBP concentration to indicate the presence, or
outcome, of severe sepsis (including septic shock) at admission and to predict the outcome of
severe sepsis (including septic shock) over 72 hours, in patients with suspected infection
following emergency department admission.
The secondary objectives of this study are to separately evaluate the performance of HBP
concentration to a) indicate the presence of severe sepsis (including severe sepsis) at
admission and b) to predict the outcome of severe sepsis (including septic shock) over 72
hours, in patients with suspected infection following emergency department admission.
Further exploratory objectives include evaluating the use of HBP measurement to indicate the
outcome of severe sepsis (including septic shock) in patients with suspected infection 12-24
hours after emergency department admission, to compare the use of HBP to other markers of
severe infection and to evaluate whether or not different cut-off values are required for the
progression and outcome measures.
outcome, of severe sepsis (including septic shock) at admission and to predict the outcome of
severe sepsis (including septic shock) over 72 hours, in patients with suspected infection
following emergency department admission.
The secondary objectives of this study are to separately evaluate the performance of HBP
concentration to a) indicate the presence of severe sepsis (including severe sepsis) at
admission and b) to predict the outcome of severe sepsis (including septic shock) over 72
hours, in patients with suspected infection following emergency department admission.
Further exploratory objectives include evaluating the use of HBP measurement to indicate the
outcome of severe sepsis (including septic shock) in patients with suspected infection 12-24
hours after emergency department admission, to compare the use of HBP to other markers of
severe infection and to evaluate whether or not different cut-off values are required for the
progression and outcome measures.
Inclusion Criteria:
- >18 years of age, suspected infection
Exclusion Criteria:
We found this trial at
5
sites
1001 South George Street
York, Pennsylvania 17403
York, Pennsylvania 17403
Principal Investigator: Brent Becker, MD
Click here to add this to my saved trials

1200 Moursund Street
Houston, Texas 77030
Houston, Texas 77030
(713) 798-4951

Principal Investigator: William Peacock, MD
Baylor College of Medicine Baylor College of Medicine in Houston, the only private medical school...
Click here to add this to my saved trials

1211 Medical Center Dr
Nashville, Tennessee 37232
Nashville, Tennessee 37232
(615) 322-5000

Principal Investigator: Wesley H Self, MD
Vanderbilt Univ Med Ctr Vanderbilt University Medical Center (VUMC) is a comprehensive healthcare facility dedicated...
Click here to add this to my saved trials

3301 Lancaster Avenue
Philadelphia, Pennsylvania 19102
Philadelphia, Pennsylvania 19102
Principal Investigator: Theodore Corbin, MD
Click here to add this to my saved trials

1020 Walnut St
Philadelphia, Pennsylvania 19107
Philadelphia, Pennsylvania 19107
(215) 955-6000

Principal Investigator: David Gaieski, MD
Thomas Jefferson University We are dedicated to the health sciences and committed to educating professionals,...
Click here to add this to my saved trials
